Avadel Pharmaceuticals Plc Stock Widgets and Gadgets
| AVDL Stock | USD 11.66 0.91 8.47% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- AVDL Avadel Pharmaceuticals PLC
- Latest Knoll Capital Management, LLCs Strategic Acquisition in Entera Bio Ltd
- AVDL 11.66 0.91
- Low 10.68
- High 11.72
- Alpha -0.53
- Beta 1.1
- Return On Equity -1.0
- Return On Asset -0.34
- Profit Margin (1.12) %
- Operating Margin (0.31) %
- Current Valuation 1.06 B
- Shares Outstanding 96.27 M
- Shares Owned By Insiders 4.77 %
- Shares Owned By Institutions 80.00 %
- Number Of Shares Shorted 9.45 M
- Price To Earning 61.46 X
- Price To Book 15.05 X
- Price To Sales 8.13 X
- Revenue 27.96 M
- Gross Profit 16.59 M
- EBITDA (149.12 M)
- Net Income (160.28 M)
- Cash And Equivalents 104.12 M
- Cash Per Share 1.74 X
- Total Debt 35.38 M
- Debt To Equity 2.63 %
- Current Ratio 2.72 X
- Book Value Per Share 0.98 X
- Cash Flow From Operations (128.51 M)
- Short Ratio 12.45 X
- Earnings Per Share (1.09) X
- Price To Earnings To Growth 0.07 X
- Target Price 24.7
- Number Of Employees 154
- Beta 1.63
- Market Capitalization 1.27 B
- Total Asset 164.7 M
- Retained Earnings (745.5 M)
- Working Capital 97.35 M
- Current Asset 177.85 M
- Current Liabilities 59.19 M
- Net Asset 164.7 M
- Accumulation Distribution 0.0887
- Daily Balance Of Power 0.875
- Rate Of Daily Change 1.08
- Day Median Price 11.2
- Day Typical Price 11.35
- Market Facilitation Index 1.04
- Price Action Indicator 0.92
- Period Momentum Indicator 0.91
Market Snapshot Widget Example
DAX Index Germany | 19,323 0.92 | |
Taiwan Weighted Taiwan | 22,904 1.55 | |
PSI 20 Stock Portugal | 6,409 0.76 | |
CROBEX Croatia | 3,118 0.21 | |
Budapest SE Hungary | 79,552 0.41 | |
IDX 30 Jakarta Indonesia | 448.67 1.38 | |
ISEQ 20 Price Ireland | 1,611 0.16 | |
NYSE Comp USA | 20,123 0.78 | |
Tel Aviv 35 Israel | 2,260 0.33 | |
Coreshares Index Tracker South Afric | 1,101 1.57 | |
IPC MEXICO Mexico | 50,437 0.53 | |
KL Technology Malaysia | 59.16 0.08 | |
IBEX 35 Index Spain | 11,657 0.39 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,533 0.22 | |
SPASX Dividend Opportunities Australia | 1,702 1.08 | |
HNX 30 Vietnam | 467.97 0.39 | |
Bucharest BET-NG Romania | 1,209 0.91 | |
AMS Small Cap Netherlands | 1,183 0.81 | |
Oslo Exchange Mutual Norway | 1,422 0.44 | |
BEL Small Belgium | 8,105 0.52 | |
Basic Materials Brazil | 5,762 1.29 | |
Swiss Leader Price Switzerland | 1,932 1.13 | |
Fondo Mutuo ETF Chile | 1,374 0.04 | |
Athens General Comp Greece | 1,402 0.28 | |
Stock Exchange Of Thailand | 1,446 0.41 | |
PX Prague Stock Czech Repub | 1,688 0.17 | |
THE PHILIPPINE STOCK Philippines | 6,780 1.21 | |
WIG 30 Poland | 2,814 0.77 | |
BIST Electricity Turkey | 489.48 1.78 |
Investing Ideas
In addition to having Avadel Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Avadel Pharmaceuticals
Compare Avadel Pharmaceuticals To Peers
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avadel Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avadel Pharmaceuticals. If investors know Avadel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avadel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.09) | Revenue Per Share 1.036 | Quarterly Revenue Growth 26.743 | Return On Assets (0.34) | Return On Equity (1.00) |
The market value of Avadel Pharmaceuticals is measured differently than its book value, which is the value of Avadel that is recorded on the company's balance sheet. Investors also form their own opinion of Avadel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Avadel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avadel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Avadel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avadel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avadel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avadel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.